LCM
ANIP icon

Legato Capital Management’s ANI Pharmaceuticals ANIP Stock Holding History

Legato Capital Management’s Portfolio ANIP Stock Details ANIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-8,370
Closed -$661K – 738
2025
Q4 		$661K Sell
8,370
-6,910
-45% -$598K 0.06% 471
2025
Q3 		$1.4M Sell
15,280
-2,770
-15% -$226K 0.15% 209
2025
Q2 		$1.18M Hold
18,050
– – 0.14% 232
2025
Q1 		$1.21M Buy
18,050
+12,010
+199% +$717K 0.16% 200
2024
Q4 		$334K Buy
+6,040
New +$347K 0.04% 487
2024
Q3 		– Sell
-7,440
Closed -$474K – 564
2024
Q2 		$474K Buy
7,440
+2,870
+63% +$186K 0.06% 452
2024
Q1 		$316K Buy
+4,570
New +$276K 0.04% 502

Other funds holding ANIP

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return